59276 Federal Register / Vol. 75, No. 186 / Monday, September 27, 2010 / Notices 

Dated: September 20, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–24139 Filed 9–24–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Clinical Center; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Board 

of Scientific Counselors of the NIH 

Clinical Center. 

The meeting will be closed to the 

public as indicated below in accordance 

with the provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

CLINICAL CENTER, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors of the NIH Clinical Center. 

Date: October 4–5, 2010. 

Time: 8 a.m. to 2 p.m. 

Agenda: To review and evaluate the 

Department of Rehabilitation Medicine. 

Place: National Institutes of Health, 

Building 10, 10 Center Drive, Room 4–2551, 

Bethesda, MD 20892. 

Contact Person: David K Henderson, MD, 

Deputy Director for Clinical Care, Office of 

the Director, Clinical Center, National 

Institutes of Health, Building 10, Room 6– 

1480, Bethesda, MD 20892, (301) 496–3515. 

This notice is being published less than 15 

days prior to the meeting due to the urgent 

need tomeet timing limitations imposed by 

the intramural research review cycle. 

Dated: September 17, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–24145 Filed 9–24–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Heart, Lung, and Blood 

Institute; Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Translational Programs in Lung Diseases. 

Date: October 14–15, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda 

(Formerly Holiday Inn Select), 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Shelley S. Sehnert, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7206, 

Bethesda, MD 20892–7924, 301–435–0303, 

ssehnert@nhlbi.nih.gov. 

Name of Committee: National Heart, Lung, 

and Blood Institute Special Emphasis Panel; 

Mentored Scientist Awards. 

Date: October 14–15, 2010. 

Time: 8:30 a.m. to 2:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Bethesda 

(Formerly Holiday Inn Select), 8120 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Holly K. Krull, PhD, 

Scientific Review Officer, Review Branch/ 

DERA, National Heart, Lung, and Blood 

Institute, 6701 Rockledge Drive, Room 7188, 

Bethesda, MD 20892–7924, 301–435–0280, 

krullh@nhlbi.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.233, National Center for 

Sleep Disorders Research; 93.837, Heart and 

Vascular Diseases Research; 93.838, Lung 

Diseases Research; 93.839, Blood Diseases 

and Resources Research, National Institutes 

of Health, HHS) 

Dated: September 21, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–24142 Filed 9–24–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Targeted Clinical Trials To 

Reduce the Risk of Antimicrobial Resistance 

(TB). 

Date: October 22, 2010. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institutes of Health, 6700B 

Rockledge Drive, 1216, Bethesda, MD 20817 

(Telephone Conference Call). 

Contact Person: Lynn Rust, PhD, Scientific 

Review Officer, Scientific Review Program, 

Division of Extramural Activities, NIAID/ 

NIH/DHHS, 6700B Rockledge Drive, MSC 

7616, Bethesda, MD 20892, (301) 402–3938, 

lr228v@nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Targeted Clinical Trials To 

Reduce the Risk of Antimicrobial Resistance 

(CAP/HCAP). 

Date: November 8, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Melrose Hotel, 2430 Pennsylvania 

Ave., NW., Potomac III, Washington, DC 

20037. 

Contact Person: Lynn Rust, PhD, Scientific 

Review Officer, Scientific Review Program, 

Division of Extramural Activities, NIAID/ 

NIH/DHHS, 6700B Rockledge Drive, MSC 

7616, Bethesda, MD 20892, (301) 402–3938, 

lr228v@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 


srobinson on DSKHWCL6B1PROD with NOTICES
Federal Register / Vol. 75, No. 186 / Monday, September 27, 2010 / Notices 59277 

Dated: September 21, 2010. 

Jennifer S. Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–24140 Filed 9–24–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 75 FR 51091–93, dated 

August 18, 2010) is amended to reflect 

the reorganization of the Division of 

Adult and Community Health within 

the National Center for Chronic Disease 

Prevention and Health Promotion, 

Office of Noncommunicable Diseases, 

Injury and Environmental Health, 

Centers for Disease Control and 

Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: 

Delete in its entirety the mission 

statement for the Division of Adult and 

Community Health (CUCE) and insert 

the following. 

Division of Adult and Community 

Health (CUCE). (1) Develops and 

promotes community-based 

interventions and programs; (2) 

provides national and international 

leadership in health education and 

health promotion; (3) conducts studies 

to enhance public health activities in 

health services and managed care; (4) 

manages public health research, 

training, cooperative, and intervention 

activities in diverse settings such as 

cities, universities, state health 

departments, and other countries; (5) 

promotes the understanding and 

improvement of the determinants and 

issues related to arthritis, aging, 

epilepsy, and emerging chronic disease 

and health promotion issues; (6) 

coordinates activities with other federal, 

state, and local governmental agencies, 

academia, and nongovernmental 

organizations, in cooperation with other 

components of NCCDPHP. 

Delete in its entirety the functional 

statement for the Office of the Director 

(CUCE1) and insert the following: 

Office of the Director (CUCEI). (1) 

Manages, coordinates, and evaluates the 

activities and programs of the division; 

(2) ensures that division activities are 

coordinated with other components of 

CDC both within and outside the center, 

with federal, state, and local health 

agencies, and with voluntary and 

professional health agencies; (3) 

provides leadership and coordinates 

division responses to requests for 

research, consultation, training, 

collaboration, and technical assistance 

or information on managed care, health 

promotion, aging, epilepsy, and 

arthritis; (4) provides administrative, 

logistical, and management support for 

division field staff; (5) provides 

administrative and management support 

for the division including guidance on 

the organization of personnel and the 

use of financial resources, and oversight 

of grants, cooperative agreements, 

contracts, and reimbursable agreements; 

(6) provides leadership and technical 

assistance to communities to promote 

policy, systems, and environmental 

changes that improve community 

health; (7) supports a network of 

academic researchers, public health 

agencies, and community members that 

conducts applied research in disease 

prevention and control. 

Delete in their entirety the title and 

functional statement for the Arthritis, 

Epilepsy and Quality of Life Branch 

(CUCc ̧) and insert the following: 

State Support, Arthritis, Epilepsy and 

Quality of Life Branch (CUCEC). (1) 

Directs and supports activities to reach 

people affected by arthritis and improve 

their quality of life by fostering public 

health science and translating science 

into population based interventions; (2) 

coordinates CDC Preventive Health and 

Health Services Block Grant (PHHSBG) 

activities and develops and administers 

guidelines, uniform reporting 

procedures, and evaluation criteria for 

state programs supported by PHHSBG; 

(3) directs and supports activities that 

improve quality of life for people 

affected by epilepsy, including 

improving access to appropriate medical 

care and self-management support, 

improving policy and systems to 

support people with epilepsy, 

supporting surveillance, epidemiologic, 

and prevention research, combating 

stigma and increasing public awareness 

and knowledge about epilepsy; (4) 

directs and administers surveillance 

efforts that provide knowledge to 

influence the public health community 

to improve health related quality of life 

and well-being through public health 

action; (5) develops, validates refines 

and promotes health-related quality of 

life and well-being measures for use in 

surveillance, program planning, 

evaluation and public health 

intervention and policy development; 

(6) directs and coordinates the 

evaluation of community and statebased intervention programs for arthritis 

and epilepsy; (7) develops arthritis and 

health-related quality of life 

epidemiology capacity and other 

programmatic capabilities in state 

health department settings; and (8) 

disseminates health promotion and 

disease prevention programs and 

information through state and national 

partners. 

Delete item (4) of the functional 

statement for the Emerging 

Investigations and Analytic Methods 

Branch (CUC1J and insert the following: 

(4) performs research on adverse 

childhood events, mental health, and 

alcohol. 

Delete in their entirety the title and 

functional statement for the Community 

Health and Program Services Branch 

(CUCEG) and insert the following: 

Community Health and Equity Branch 

(CUCEG). (1) Provides technical 

assistance to state and local health 

agencies, community-based 

organizations, academic institutions, 

and other federal, national, and 

international organizations to plan, 

implement, and evaluate communitybased chronic disease prevention and 

health promotion programs, with an 

emphasis on improving equity and 

reducing disparities; (2) develops, 

implements, and evaluates training in 

the areas of chronic disease 

intervention, social determinants of 

health, and community health 

promotion for state and local health 

departments, other agencies, and 

community organizations; (3) supports 

health promotion and disease 

prevention research conducted at 

university-based prevention centers; (4) 

develops chronic disease epidemiology 

capacity in state health departments 

through training and support of chronic 

disease field epidemiologists and other 

capacity building efforts; (5) provides 

professional statistical and 

programming services to the division, 

including assistance in design of data 

collection instruments, computer 

programming, and statistical analysis; 

(6) provides administrative and 

management support for the branch, 

including oversight of grants, 

cooperative agreements, contracts, and 

reimbursable agreements. 


srobinson on DSKHWCL6B1PROD with NOTICES